OPPapers.com Essay Index >> Business >> Problem Solution: Geneone
We have many free term papers and essays on Problem Solution: Geneone. We also have a wide variety of research papers and book reports available to you for free. You can browse our collection of term papers or use our search engine.
Problem Solution: GeneOne. Running head: PROBLEM SOLUTION: GENEONE Problem
Solution: GeneOne xxxxx University of Phoenix Problem ...
PROBLEM SOLUTION: GENEONE. Running head: PROBLEM SOLUTION: GENEONE Problem
Solution: Gene One Roy Carter University of Phoenix April ...
... Running head: PROBLEM SOLUTION: GENEONE Problem Solution: GeneOne Your Name Goes
Here University of Phoenix Problem Solution: GeneOne [Triple click anywhere in ...
GeneOne Problem Solution. Problem Solution: GeneOne Gene One is a cutting edge biotech
company that has grown into a $400 million company in just eight years. ...
GeneOne problem Solution. Problem Solution: Gene One Gene One entered the
biotech industry with groundbreaking gene technology that ...
Submitted by cjsmommy2002 on June 8, 2007
Category: Business
Words: 2450 | Pages: 10
Views: 617
Popularity Rank: 12,329
Average Member Grade: N/A (Add a Comment / Grade this Paper)
Running head: PROBLEM SOLUTION: GENEONE
Problem Solution: GeneOne
xxxxx
University of Phoenix
Problem Solution: GeneOne
GeneOne is a biotechnology firm that is considering going public. There are many issues and opportunities that face GeneOne in this endeavor. To successfully implement the initial public offering (IPO), GeneOne must follow the nine-step problem-solving process to determine the issues, find the core problem, identify risks, and find the optimal solution.
Situation Analysis
Issue and Opportunity Identification
There are many opportunities facing GeneOne in the next three years. The CEO and the Board with the help of key members in the investment community have devised a clear strategy to take the firm public. All of these opportunities are chance for GeneOne to realize its goal of 40% growth over the next 36 months.
The lack of IPO experience of the board of directors and the key employees is the first opportunity for GeneOne. The Sarbanes-Oxley Act (SOA) is 66 pages of information. GeneOne needs to know this information to be in compliance with the act. Such rules include corporate disclosure, compliance, fraud, and accountability (Sarbanes-Oxley Act, 2002).
GeneOne’s leadership is seeing personality conflicts. Teri Robertson feels that Michelle Houghton belittles her research and the work it takes (University of Phoenix, 2007). This issue could lead to further conflicts unless solutions are reached for the group begins to work as a team.
GeneOne’s prospect of an IPO is becoming public knowledge (University of Phoenix). If not handled properly the release of this information could lead to high turnover among the employees. Potential shareholders could also view information negatively if not released in the proper manner.
Team building is another opportunity for GeneOne. The leadership group must build a bond. A team must...
You must Login to view the entire paper.
If you are not a member yet, Sign Up for free!